150534-59-1

Basic information

• Product Name: 9-bromo-5-(p-methoxycarbonyl-m-chlorophenylcarbamoylmethyl)-6,7-dihydro-1H, 5H-pyrido[1,2,3-de]quinoxaline-2,3-dione
• Synonyms: 9-bromo-5-(p-methoxycarbonyl-m-chlorophenylcarbamoylmethyl)-6,7-dihydro-1H, 5H-pyrido[1,2,3-de]quinoxaline-2,3-dione
• CAS NO: 150534-59-1
• Molecular Weight: 506.74
• Mol File: 150534-59-1.mol

Chemical Properties

• CAS DataBase Reference: 9-bromo-5-(p-methoxycarbonyl-m-chlorophenylcarbamoylmethyl)-6,7-dihydro-1H, 5H-pyrido[1,2,3-de]quinoxaline-2,3-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 9-bromo-5-(p-methoxycarbonyl-m-chlorophenylcarbamoylmethyl)-6,7-dihydro-1H, 5H-pyrido[1,2,3-de]quinoxaline-2,3-dione(150534-59-1)
• EPA Substance Registry System: 9-bromo-5-(p-methoxycarbonyl-m-chlorophenylcarbamoylmethyl)-6,7-dihydro-1H, 5H-pyrido[1,2,3-de]quinoxaline-2,3-dione(150534-59-1)

Safety Data

• Hazardous Substances Data: 150534-59-1(Hazardous Substances Data)

Upstream product

• 150533-87-2 6-bromo-5-<(methoxycarbonyl)methyl>-6,7-dihydro-1H,5H-pyrido<1,2,3-de>quinoxaline-2,3-dione 
• 150535-18-5 6-bromo-2-<(methoxycarbonyl)methyl>-8-nitro-N-ethoxalyltetrahydroquinoline 
• 46004-37-9 methyl 4-amino-2-chlorobenzoate 
• 150533-88-3 9-bromo-5-carboxymethyl-6,7-dihydro-1H,5H-pyrido[1,2,3-de]-quinoxaline-2,3-dione 

Downstream Products

• 150534-60-4 9-bromo-5-(p-carboxy-m-chlorophenylcarbamoylmethyl)-6,7-dihydro-1H, 5H-pyrido[1,2,3-de]quinoxaline-2,3-dione 

Relevant articles and documents

Tricyclic quinoxalinediones

Tricyclic quinoxalinediones of the formula: STR1 wherein X is alkyl, halogen, cyano, trifluoromethyl, nitro, hydroxy, amino, etc.; R 1 is H, etc.; R 2 is H, alkyl, cycloalkyl, alkenyl, alkynyl, cycloalkylalkyl, arylalkyl, substituted arylalkyl, aryl, or substituted aryl; W is H, CO 2 R 3, CO 2 Y, CONR 3 R 4, CONR 3 Y, CON(OR 3)R 4, COR 3, CN, tetrazolyl, or substituted alkyl; R 3 and R 4 independently are H, alkyl, cycloalkyl, alkenyl, alkynyl, etc.; Y is mono-substituted alkyl or di-substituted alkyl; and n is an integer 0 or 1, or a pharmaceutically acceptable salt thereof, which are useful as a selective antagonist of glutamate receptor for the treatment or prevention of various diseases in animals including human being, for example, minimizing damage of central nervous system induced by ischaemic or hypoxylic conditions, treatment and/or prevention of neurodegenerative disorders, and further analgesics, antidepressants, anxiolitics, and anti-schizophrenics.